Barrow Hanley Mewhinney & Strauss LLC Amphastar Pharmaceuticals, Inc. Transaction History
Barrow Hanley Mewhinney & Strauss LLC
- $26.4 Billion
- Q1 2025
A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 20 shares of AMPH stock, worth $502. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$502% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
264Shares Held
32.5MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$149 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$60.9 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.6 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.1 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.23B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...